LncRNA growth arrest‐specific transcript 5 targets miR‐21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN

LncRNA growth arrest‐specific transcript 5 targets miR‐21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN

Abstract The aim of this study was to investigate the mechanism by which growth arrest‐specific transcript 5 (GAS5) regulates bladder cancer cells. Bladder cancer samples were collected and tested for experiment. Dual‐luciferase reporter assay was used to verify the downstream target genes for GAS5...

Full description

Bibliographic Details
Main Authors:	Dong Chen, Yihong Guo, Yaqiu Chen, Qiaonan Guo, Junyi Chen, Yining Li, Qiuping Zheng, Minyao Jiang, Ming Xi, Lu Cheng
Format:	Article
Language:	English
Published:	Wiley 2020-04-01
Series:	Cancer Medicine
Subjects:	bladder cancer growth arrest‐specific transcript 5 long noncoding RNAs miR‐21
Online Access:	https://doi.org/10.1002/cam4.2664

Similar Items

Differential Expression of LncRNA in Bladder Cancer Development
by: Lorenzo Spirito, et al.
Published: (2023-05-01)

The role of miRNA and lncRNA in heterotopic ossification pathogenesis
by: Łukasz Pulik, et al.
Published: (2022-12-01)

The Novel Regulatory Role of the lncRNA–miRNA–mRNA Axis in Chronic Inflammatory Airway Diseases
by: Xin Qiao, et al.
Published: (2022-06-01)

Exploring lncRNA Expression Patterns in Patients With Hypertrophied Ligamentum Flavum
by: Junling Chen, et al.
Published: (2024-03-01)

Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies
by: Amirreza Mehmandar-Oskuie, et al.
Published: (2023-09-01)

Prognostic significance and identification of basement membrane-associated lncRNA in bladder cancer
by: Lixiang Feng, et al.
Published: (2022-10-01)

Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
by: Shan Hua, et al.
Published: (2021-07-01)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
by: Mei Chen, et al.
Published: (2021-11-01)

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
by: Caixiang Zhang, et al.

LncRNA MALAT1: A Potential Fibrosis Biomarker and Therapeutic Target
by: Yijie Li, et al.
Published: (2021-02-01)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
by: Lihong Yang, et al.
Published: (2023-06-01)

Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer
by: Zhenming Zheng, et al.
Published: (2021-08-01)

A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
by: Jinming Cai, et al.
Published: (2023-01-01)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
by: Lianghao Zhang, et al.
Published: (2021-01-01)

Effect of glucocorticoids on lncRNA and mRNA expression profiles of the bone microcirculatory endothelial cells from femur head of Homo sapiens
by: Qingsheng Yu, et al.
Published: (2015-06-01)

LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c‐MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer
by: Jinbo Xie, et al.
Published: (2023-03-01)

LncRNA GAS5 Suppressed Proliferation and Promoted Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting MiR-26a-5p and Modifying ULK2
by: Wang J, et al.
Published: (2021-01-01)

Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma
by: Danyan Gu, et al.
Published: (2023-05-01)

Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells
by: Chen Yuan, et al.
Published: (2023-06-01)

LncRNA LOC285194 modulates gastric carcinoma progression through activating Wnt/β‐catenin signaling pathway
by: Bingzheng Zhong, et al.
Published: (2020-03-01)

A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas
by: Sen Cheng, et al.
Published: (2021-10-01)

An integrated analysis reveals the oncogenic function of lncRNA LINC00511 in human ovarian cancer
by: Jing Wang, et al.
Published: (2019-06-01)

AL355338 acts as an oncogenic lncRNA by interacting with protein ENO1 to regulate EGFR/AKT pathway in NSCLC
by: Qian Hua, et al.
Published: (2021-10-01)

Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer
by: Lyu L, et al.
Published: (2019-07-01)

Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells
by: Przemysław A. Stempor, et al.
Published: (2021-03-01)

Parthenolide Induces Apoptosis and Cell Cycle Arrest of Human 5637 Bladder Cancer Cells In Vitro
by: Guang Cheng, et al.
Published: (2011-08-01)

LncRNA MRF drives the regulatory function on monocyte recruitment and polarization through HNRNPD-MCP1 axis in mesenchymal stem cells
by: Jiajie Lin, et al.
Published: (2022-09-01)

An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism
by: Jiali Liang, et al.
Published: (2022-11-01)

A Novel lncRNA SAAL Suppresses IAV Replication by Promoting Innate Responses
by: Qingzheng Liu, et al.
Published: (2022-11-01)

m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer
by: Zi-Hao Feng, et al.
Published: (2022-10-01)

Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
by: Huijie Wu, et al.
Published: (2021-10-01)

The Role of Long Noncoding RNAs (lncRNAs) in Esophageal Cancer Therapy Resistance and Metastasis
by: Zong-Ping Weng, et al.
Published: (2024-03-01)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
by: Dongjie Shi, et al.
Published: (2022-08-01)

Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer
by: Yingchun Liang, et al.
Published: (2021-09-01)

Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome
by: YiHeng Du, et al.
Published: (2021-03-01)

Truncated Isoforms of lncRNA ANRIL Are Overexpressed in Bladder Cancer, But Do Not Contribute to Repression of INK4 Tumor Suppressors
by: Michèle J. Hoffmann, et al.
Published: (2015-12-01)

Upregulation of Superenhancer‐Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma
by: Jiang‐Yun Peng, et al.
Published: (2023-01-01)

LncRNA4667 is dispensable for spermatogenesis and fertility in mice
by: Yu-Bing Dai, et al.
Published: (2019-01-01)

Oncogenic Dysregulation of Circulating Noncoding RNAs: Novel Challenges and Opportunities in Sarcoma Diagnosis and Treatment
by: Lidia Chellini, et al.
Published: (2022-09-01)

The Landscape of Regulatory Noncoding RNAs in Ewing’s Sarcoma
by: Connor Barrett, et al.
Published: (2021-07-01)